Topline Pfizer and BioNTech could finish work by the fall on a new version of its Covid-19 vaccine that can better protect against the omicron variant while still being effective against other known s...
Topline Pfizer and BioNTech could finish work by the fall on a new version of its Covid-19 vaccine that can better protect against the omicron variant while still being effective against other known s...